Utah Medical Products UTMD Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's allowance for doubtful accounts receivable (current)?
- Utah Medical Products (UTMD) reported allowance for doubtful accounts receivable (current) of $515K in Q4 2025.
- How has Utah Medical Products's allowance for doubtful accounts receivable (current) changed year-over-year?
- Utah Medical Products's allowance for doubtful accounts receivable (current) increased by 260.1% year-over-year, from $143K to $515K.
- What is the long-term trend for Utah Medical Products's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Utah Medical Products's allowance for doubtful accounts receivable (current) has grown at a 30.9% compound annual growth rate (CAGR), from $134K to $515K.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.